- Tumor Homing Statin Derivatives
-
The present invention generally relates to tumor homing statin derivatives (THSD) and their use for therapy, in particular cancer therapy. These THSD comprise three moieties: a statin moiety which comprises a dihydroxyheptanoic acid unit (DHHA) fixated by linkage into its open chain form, a heptamethine carbocyanine dye (HMCD) moiety, and a linker that conjugates the DHHA of the statin to the dye moiety. The linker is linked to the DHHA via an ester bond (ester-linked statin derivative or ELSD), or via an amide bond (amide-linked statin derivative or ALSD). Thus linked to the DHHA, the linker provides a relatively stable link either for essentially no hydrolysis/statin release after administration, or preferably for very slow hydrolysis and statin release, as is the case for the ELSD. Embodiments include methods to provide the desired THSD, in particular the ELSD, with the DHHA in its open chain form. The invention also relates to methods wherein one or more ELSD is administered to a patient in a therapeutically effective amount, and methods wherein an ELSD and an ALSD are co-administered in a coordinated administration schedule. Advantages of the THSD and their use include, among others, improved efficacy and dose-response, and decreased statin-associated side effects.
- -
-
Paragraph 0245-0247
(2021/01/25)
-
- Tumor-targeted statin derivatives, medicine formula and application
-
The invention relates to tumor-targeted statin derivatives (THSD) and application thereof in therapy, particularly cancer therapy. The THSDs comprise the following three parts: a statin part comprising a dihydroxyheptanoic acid unit (DHHA) maintaining an
- -
-
Page/Page column 12; 43-44
(2020/01/08)
-
- METHODS FOR MAKING SIMVASTATIN AND INTERMEDIATES
-
The invention provides synthetic chemical and chemoenzymatic methods of producing simvastatin and various intermediates. In one aspect, enzymes such as hydrolases, e.g., esterases, are used in the methods of the invention.
- -
-
Page/Page column 73-74
(2008/06/13)
-
- Process to simvastatin ester
-
A process is disclosed, for the formation of simvastatin, which comprises the sequential acylation of a diol lactone to form a bis acylated intermediate followed by selective deacylation and lactone ring closure to form simvastatin.
- -
-
-